| Literature DB >> 24009846 |
Van Anh Vo1, Jae-Won Lee, Ji-Eun Chang, Ji-Young Kim, Nam-Ho Kim, Hee Jae Lee, Sung-Soo Kim, Wanjoo Chun, Yong-Soo Kwon.
Abstract
suppresAvicularin, quercetin-3-α-L-arabinofuranoside, has been reported to possess diverse pharmacological properties such as anti-inflammatory and anti-infectious effects. However, the underlying mechanism by which avicularin exerts its anti-inflammatory activity has not been clearly demonstrated. This study aimed to elucidate the anti-inflammatory mechanism of avicularin in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells. Avicularin significantly inhibited LPS-induced excessive production of pro-inflammatory mediators such as nitric oxide (NO) and PGE2 and the protein levels of iNOS and COX-2, which are responsible for the production of NO and PGE2, respectively. Avicularin also suppressed LPS-induced overproduction of pro-inflammatory cytokine IL-1β. Furthermore, avicularin significantly suppressed LPS-induced degradation of IκB, which retains NF-κB in the cytoplasm, consequently inhibiting the transcription of pro-inflammatory genes by NF-κB in the nucleus. To understand the underlying signaling mechanism of anti-inflammatory activity of avicularin, involvement of multiple kinases was examined. Avicularin significantly attenuated LPS-induced activation of ERK signaling pathway in a concentration-dependent manner. Taken together, the present study clearly demonstrates that avicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells.Entities:
Keywords: Avicularin; COX-2; Lipopolysaccharide; NF-κB; RAW 264.7 cells; iNOS
Year: 2012 PMID: 24009846 PMCID: PMC3762284 DOI: 10.4062/biomolther.2012.20.6.532
Source DB: PubMed Journal: Biomol Ther (Seoul) ISSN: 1976-9148 Impact factor: 4.634
Fig. 1.Chemical structure of avicularin.
Fig. 2.Avicularin significantly attenuated LPS-induced overproduction of NO (A) and PGE2 (B) in RAW 264.7 macrophage cells. RAW 264.7 cells were pretreated with various concentrations of avicularin for 1 hr before incubation with LPS (200 ng/ml) for 24 hr. (A) The amount of nitrite in the supernatants was measured using Griess reagent. Avicularin exhibited a significant suppression of LPS-induced NO production in a concentration-dependent manner. (B) To measure the amount of PGE2 secretion, culture media were subjected to PGE2 ELISA. PGE2 secretion was significantly suppressed with avicularin in a concentration-dependent manner. (C) Effect of avicularin on the viability of RAW 264.7 cells. No noticeable cell death was observed with avicularin concentrations used in the present study. The data are expressed as mean ± S.D. (n=3), and are representative of three or more independent experiments. *p<0.05 and **p<0.01 indicate statistically significant differences from treatment with LPS alone. ##p<0.01 indicates statistically significant difference between indicated groups.
Fig. 3.Avicularin significantly suppressed LPS-induced iNOS and COX-2 expressions in RAW 264.7 cells. (A) The cell lysates were subjected to SDS-PAGE, and then protein levels of iNOS and COX-2 were determined by Western blot analysis. (B) Quantitative analysis of iNOS and COX-2 expression was performed by densitometric analysis. The β-actin was used as an internal control. Avicularin significantly attenuated LPS-induced overexpression of iNOS and COX-2. Images are representative of three independent experiments that shows consistent results. *p<0.05 and **p<0.01 indicate statistically significant differences from treatment with LPS alone.
Fig. 4.Avicularin inhibited the release IL-1β (A), but not TNF-α (B) in LPS-stimulated RAW 264.7 macrophage cells. Cells were pretreated with the indicated concentrations of avicularin for 1 hr before LPS treatment (200 ng/ml), cell culture media were collected and subjected to TNF-α and IL-1β ELISA. Avicularin significantly attenuated LPS-induced IL-1β secretion, but did not affect on TNF-α. Data represent three independent experiments in triplicate and are expressed as mean ± SD. *p<0.05 and **p<0.01 indicate statistically significant differences from treatment with LPS alone. ##p<0.01 indicates statistically significant difference between indicated groups.
Fig. 5.Avicularin suppressed LPS-induced IκB-α degration in RAW 264.7 macrophage cells. (A) Total cell lysates obtained 15 min after the LPS stimulation were subjected to Western blotting to measure the levels of IκB-α degradation. (B) Quantification of IκB-α degradation was performed by densitometric analysis. The β-actin was used as an internal control. Data from triplicate determination are shown (mean ± S.D.). *p<0.05 and **p<0.01 indicate statistically significant differences from treatment with LPS alone.
Fig. 6.Avicularin inhibited LPS-stimulated ERK signaling pathway in RAW 264.7 macrophage cells. RAW 264.7 cells were stimulated with 200 ng/ml LPS in the absence or presence of avicularin. (A) Western blot analysis was then performed to evaluate the activation of MAP kinases signaling pathways. (B) Ratio of phosphorylated forms to native forms was carried out by densitometric analysis. LPS-induced phosphorylation of ERK was significantly attenuated with aviculairn treatment, but phosphorylation of JNK and p38 was not decreased with avicularin treatment. Phosphorylation of MEK, upstream kinase of ERK, was accordingly attenuated with avicularin, suggesting that MEK/ERK might play an important role in the LPS-induced overactivation of RAW 264.7 cells. β-Actin was used as an internal control. Images are representative of three independent experiments that shows reproducible results. *p<0.05 and **p<0.01 indicate statistically significant differences from treatment with LPS alone.